EBAC
NASDAQ:EBACU
European Biotech Acquisition Corp.
- Stock
Last Close
11.71
02/03 21:00
Market Cap
183.50M
Beta: -
Volume Today
77.64K
Avg: 1.53K
PE Ratio
40.74
PFCF: −356.46
Dec '21 | Dec '22 | ||
---|---|---|---|
asset turnover | |||
cash per share | 0.02 - | ||
company equity multiplier | 1.06 - | 1.07 0.71% | |
days of inventory outstanding | |||
days of payables outstanding | |||
days of sales outstanding | |||
dividend yield | |||
ebit per revenue | |||
ebt per ebit | -1.34 - | -0.12 90.95% | |
effective tax rate | -1.74 - | -9.22 428.62% | |
enterprise value multiple | 0.24 - | -21.43 9,179.00% | |
fixed asset turnover | |||
free cash flow per share | -0.04 - | ||
gross profit margin | |||
interest coverage | 0.21 - | 0.45 109.01% | |
inventory turnover | |||
long term debt to capitalization | |||
net income per ebt | 2.74 - | 10.22 272.41% | |
net profit margin | |||
operating cash flow per share | -0.04 - | ||
operating profit margin | |||
payables turnover | |||
pretax profit margin | |||
price fair value | 1.06 - | ||
receivables turnover | |||
return on assets | 0.03 - | 0.03 14.49% | |
return on capital employed | -0.01 - | -0.02 154.25% | |
return on equity | 0.03 - | 0.03 13.89% | |
total debt to capitalization |
All numbers in USD (except ratios and percentages)